CDK4/6 inhibitor resistance: A bibliometric analysis

BACKGROUND: Cyclin-dependent kinases (CDKs) 4/6 inhibitors are a type of cell cycle regulation that prevents cell proliferation by blocking retinoblastoma protein (Rb) phosphorylation in the G1 to S phase transition. CDK 4/6 inhibitors are currently used mainly in patients with hormone receptor-posi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pang, Jiayuecheng, Li, Hengyu, Sheng, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752919/
https://www.ncbi.nlm.nih.gov/pubmed/36530984
http://dx.doi.org/10.3389/fonc.2022.917707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752919/
https://www.ncbi.nlm.nih.gov/pubmed/36530984
http://dx.doi.org/10.3389/fonc.2022.917707

Ejemplares similares